The podophyllotoxin-derived topoisomerase II inhibitors etoposide and teniposide inhibited MYB activity in a cell-based screening assay and promoted MYB degradation in MYC-driven NB4, HL-60, and U937 AML cells[236]. This evidence concerns the gene MYC and acute myeloid leukemia.